Search - tctmd.com

Displaying 41 - 60 of 484

Sort: Relevancy | Date

News Conference News EuroPCR 2025

Meta-analysis Quashes Hopes for Routine Embolic Protection in TAVI

Michael O'Riordan

May 21, 2025

News Conference News EuroPCR 2025

Early TAVI Improves Prognosis in Asymptomatic AS No Matter the Extent of Cardiac Damage

Yael L. Maxwell

May 21, 2025

News Opinion CV Team Dispatch

May 2025 Dispatch for the CV Team

L.A. McKeown

May 20, 2025

News Daily News

AHA/ACC Issue New Performance, Quality Measures for Chronic Coronary Disease

Caitlin E. Cox

May 06, 2025

News Conference News CX Symposium 2025

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

L.A. McKeown

April 24, 2025

News Conference News CRT 2025

SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years

L.A. McKeown

March 10, 2025

News Conference News CRT 2025

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

L.A. McKeown

March 10, 2025

News Daily News

Intravascular Imaging During PCI Should Be a Performance Metric, Researchers Say

Todd Neale

February 11, 2025

News Daily News

Deferred Revascularization Safer When Guided by FFR vs QFR: FAVOR III Europe

Caitlin E. Cox

January 09, 2025

News Daily News

Immediate Angiography in OHCA Without STEMI Could Harm: TOMAHAWK and COACT

Caitlin E. Cox

December 27, 2024

News Daily News

Some Guidance for Managing Patients With AS and CAD: Review

Yael L. Maxwell

December 24, 2024

News Opinion Conversations in Cardiology

All Eyes on PCI—Should Patients’ Family Members Watch Cases?

December 19, 2024

News Conference News PCR London Valves 2024

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Michael O'Riordan

November 26, 2024

News Conference News PCR London Valves 2024

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Michael O'Riordan

November 25, 2024

News Conference News VIVA 2024

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

L.A. McKeown

November 06, 2024

News Conference News TCT 2024

CONFIRM2 Shows Power of AI-QCT to Use Plaque Features to Predict CAD Events

Yael L. Maxwell

November 01, 2024

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

News Conference News TCT 2024

QFR No Match for FFR in Guiding Revascularizations: FAVOR III Europe

Caitlin E. Cox

October 30, 2024

News Conference News TCT 2024

Preprocedural AI-QCA Matches OCT-Guided PCI for Noncomplex Lesions

Yael L. Maxwell

October 30, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

Advertisement

Meta-analysis Quashes Hopes for Routine Embolic Protection in TAVI

Early TAVI Improves Prognosis in Asymptomatic AS No Matter the Extent of Cardiac Damage

May 2025 Dispatch for the CV Team

AHA/ACC Issue New Performance, Quality Measures for Chronic Coronary Disease

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

Intravascular Imaging During PCI Should Be a Performance Metric, Researchers Say

Deferred Revascularization Safer When Guided by FFR vs QFR: FAVOR III Europe

Immediate Angiography in OHCA Without STEMI Could Harm: TOMAHAWK and COACT

Some Guidance for Managing Patients With AS and CAD: Review

All Eyes on PCI—Should Patients’ Family Members Watch Cases?

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

CONFIRM2 Shows Power of AI-QCT to Use Plaque Features to Predict CAD Events

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

QFR No Match for FFR in Guiding Revascularizations: FAVOR III Europe

Preprocedural AI-QCA Matches OCT-Guided PCI for Noncomplex Lesions

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content